SCHEMBL183356

SCHEMBL183356

[CH2]CCC=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL165972 0.77
SCHEMBL168949 0.74
SCHEMBL168854 0.72 TRPA1 (0.31)
SCHEMBL166888 0.72
SCHEMBL8734069 0.72 TRPA1 (0.31)
SCHEMBL165910 0.72 TRPA1 (0.31)
SCHEMBL8579729 0.72 TRPA1 (0.31)
SCHEMBL320565 0.72 TRPA1 (0.31)
SCHEMBL183105 0.72
SCHEMBL183299 0.72 TRPA1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1016 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116920123-A Toremifene cyclodextrin inclusion and preparation method thereof 重庆士立德医药科技有限公司 2023-10-24 CN claimed
CN-105228605-B Thiosyl mucolytic agents 加利福尼亚大学董事会 2022-08-12 CN claimed
US-20220185846-A1 METHODS FOR SYNTHESIZING BETA-HOMOAMINO ACIDS PROTAGONIST THERAPEUTICS, INC. 2022-06-16 US claimed
EP-3953376-A1 METHODS FOR SYNTHESIZING BETA-HOMOAMINO ACIDS Protagonist Therapeutics, Inc. (US) 2022-02-16 EP claimed
CN-113631569-A Process for the synthesis of beta-homoamino acids 领导医疗有限公司 2021-11-09 CN claimed
WO-2020198682-A1 METHODS FOR SYNTHESIZING β-HOMOAMINO ACIDS PROTAGONIST THERAPEUTICS, INC. (US) 2020-10-01 WO claimed
EP-3191482-B1 1,2,3-THIADIAZOL-5YL-UREA DERIVATIVES, USE THEREOF FOR REGULATING PLANT SENESCENCE AND PREPARATIONS CONTAINING THESE DERIVATIVES USTAV EXPERIMENTALNI BOTANIKY AV CR V V I (CZ) 2019-03-27 EP claimed
EP-2968215-A2 THIOSACCHARIDE MUCOLYTIC AGENTS The Regents of The University of California (US) 2016-01-20 EP claimed
CN-105228605-A Thiosyl mucolytic agents UNIV CALIFORNIA 2016-01-06 CN claimed
WO-2014153009-A2 THIOSACCHARIDE MUCOLYTIC AGENTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION (US) 2014-09-25 WO claimed
WO-2000036136-A1 METALLOPEPTIDE COMBINATORIAL LIBRARIES AND APPLICATIONS PALATIN TECHNOLOGIES, INC. (US) 2000-06-22 WO claimed
WO-2000032567-A1 3,4,5-TRISUBSTITUTED ARYL NITRONE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME CENTAUR PHARMACEUTICALS, INC. (US) 2000-06-08 WO claimed
WO-1992006081-A1 ANILIDE DERIVATIVES WITH ANGIOTENSIN II ANTAGONIST PROPERTIES WARNER-LAMBERT COMPANY (US) 1992-04-16 WO claimed
US-5045540-A Amide or urea compounds containing imidazole groups WARNER-LAMBERT CO. (US) 1991-09-03 US claimed
US-5041552-A Treatment of hypertension, heart failure, glaucoma and hyperaldosteronism WARNER-LAMBERT COMPANY (US) 1991-08-20 US claimed
US-4833148-A ANTIISCHEMIA AGENTS WASHINGTON UNIVERSITY (US) 1989-05-23 US claimed
US-4739053-A CHARGE CARRIER-TRANSPORTING COMPOUNDS; ELECTROGRAPHY BASF AKTIENGESELLSCHAFT (DE) 1988-04-19 US claimed
EP-0148096-B1 DIVERSELY SUBSTITUTED 1-ARYLAMINO-3-AMINO-2-PROPANOLS, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTICAL APPLICATION CORTIAL S.A. (FR) 1987-08-05 EP claimed
EP-0116341-A1 2H-V-Triazolyl(4,5-D)-pyrimidines and their use BASF Aktiengesellschaft (DE) 1984-08-22 EP claimed
US-4375525-A Use of organic silicon compounds for stabilizing and brightening polycarbonates which are free from phosphites and free from boric acid esters BAYER AKTIENGESELLSCHAFT (DE) 1983-03-01 US claimed